Farmacia y farmacología

2026

1. A multiscale approach to lipid nanoparticle engineering from molecular structure to in vivo performance

   Journal of Controlled Release, Vol. 394

2. A systematic review on age-related macular degeneration: New insights from multi-omics studies

   Survey of Ophthalmology, Vol. 71, Núm. 4, pp. 1058-1073

3. Abordaje ético del manejo del dolor en el paciente pediátrico en situación terminal: una revisión sistemática

   Farmacia Hospitalaria, Vol. 50, Fasc. 2, pp. T128-T135

4. Analytical and Clinical Validation of Action PharmaKitDx: A Comprehensive NGS Panel for the Identification of Pharmacogenetic Variants in Diverse Populations

   Pharmaceuticals, Vol. 19, Núm. 4, pp. 568

5. Artificial intelligence-based identification of key risk factors for long COVID from early clinical data

   Journal of Infection and Public Health, Vol. 19, Núm. 1

6. Automation and standardization in parenteral nutrition compounding — Automated compounding systems and multi-chamber bags

   Nutricion Hospitalaria, Vol. 43, Núm. Extra 2, pp. 43-50

7. Bile Acid: Drivers, Carriers and Trojan Horses in Cancer Research

   Targets, Vol. 4, Núm. 2, pp. 18

8. Biosimilar eculizumab and meningococcal meningitis: the importance of strengthening health education

   Ars pharmaceutica, Vol. 67, Núm. 1, pp. 6-8

9. Calcium-phosphate compatibility in parenteral nutrition: critical review and recommendations for safe formulation

   Nutricion Hospitalaria, Vol. 43, Núm. EXT2, pp. 9-16

10. Clinical translation of injectable hydrogels: from bioactive polymers to long-acting drug delivery systems

    Drug Delivery and Translational Research, Vol. 16, Núm. 6, pp. 1685-1708

11. Delivery of monoclonal antibodies to the brain: the impact of nanocarrier structure

    Drug Delivery and Translational Research, Vol. 16, Núm. 3, pp. 780-796

12. Deprescribing Through the LESS-CHRON Tool: Recruitment Data and Results of Impact on Pharmacological Treatment (LESS-CHRON Validation Project)

    Journal of the American Geriatrics Society, Vol. 74, Núm. 4, pp. 975-989

13. Design and characterization of intravitreal bevacizumab-loaded PLGA nanoparticles: pharmacokinetic and biodistribution impact

    Drug Delivery and Translational Research, Vol. 16, Núm. 4, pp. 1262-1284

14. Discovery of first-in-class melanostatin-based ago-allosteric modulators of the dopamine D2 receptors

    Biomedicine and Pharmacotherapy, Vol. 196

15. Drug compatibility with parenteral nutrition — Recommendations for evaluation and safe coadministration

    Nutricion Hospitalaria, Vol. 43, Núm. EXT.2, pp. 51-59

16. Elevated Plasma GDF-15 Levels Are Associated with Aging, Multimorbidity, and Tobacco Exposure in People with HIV

    Infectious Diseases and Therapy, Vol. 15, Núm. 3, pp. 715-731

17. Estimating the Clinical, Quality-of-Life and Economic Impact of Optimized Management of Type 2 Diabetes Patients in Spain

    Journal of Clinical Medicine, Vol. 15, Núm. 4

18. Evaluación de la herramienta de e-consulta entre farmacéutico de atención primaria y médico especialista en medicina familiar y comunitaria en la resolución de prescripciones potencialmente inapropiadas y problemas relacionados con los medicamentos

    Semergen: revista española de medicina de familia, Núm. 2

19. Experience with isavuconazole in lung transplant recipients with Aspergillus isolation in respiratory tract specimens: A multicenter, observational study

    JHLT Open, Vol. 11

20. First-in-class SAM-competitive G9a inhibitor FLAV-27 as a disease-modifying therapy for Alzheimer disease

    Molecular Therapy, Vol. 34, Núm. 4, pp. 2372-2407